Day: December 9, 2024
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) — Serve Robotics Inc. (Nasdaq: SERV), a leading embodied AI and automation company, today announced the appointment of Lily Sarafan to its Board of Directors (the “Board”).
Sarafan is an accomplished leader with nearly 20 years of experience in entrepreneurship, executive leadership and board governance. She is co-founder and former chief executive of TheKey, one of the largest and most trusted in-home care provider networks, where she serves as executive chair. Sarafan currently serves on the boards of Instacart, Thumbtack and Kyo as well as on the board of trustees of Stanford University. She has been recognized as an EY Entrepreneur of the Year, a Fortune 40 Under 40, Women Health Care Executives’ Woman of the Year, and a Henry Crown Fellow of the Aspen Institute....
Compass Diversified to Host Investor Day on January 16, 2025, in New York City
Written by Customer Service on . Posted in Public Companies.
WESTPORT, Conn., Dec. 09, 2024 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, today announced that it will host its investor day on Thursday, January 16, 2025, at 9:30am ET at Convene’s One Liberty Plaza location in New York City.
The event will include a presentation by CODI’s executive management team followed by a Q&A session, as well as a panel discussion moderated by CODI CEO, Elias Sabo with the CEOs of 5.11 Tactical, PrimaLoft, and Altor Solutions. A summary agenda is provided below. All times in EST.• 9:30am – 10:00am:
Participant check-in and continental breakfast• 10:00am – 11:30pm:
Compass Diversified presentation and Q&A session• 11:30am – 12:30pm:
Moderated panel discussion• 12:30pm – 1:30pm:
Lunch and self-guided,...
Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Written by Customer Service on . Posted in Public Companies.
WEST CHESTER, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Verrica’s Compensation Committee granted David Zawitz, Verrica’s new Chief Operating Officer, a nonqualified stock option to purchase 950,000 shares of its common stock under the Company’s Inducement Plan, effective December 9, 2024. The stock option was granted as a material inducement to Mr. Zawitz’s employment with Verrica in accordance with Nasdaq Listing Rule 5635(c)(4).
The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Verrica (or following a bona fide period of non-employment),...
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
Written by Customer Service on . Posted in Public Companies.
Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further evaluation in a randomized trial
23 months median Overall Survival from date of diagnosis was observed in 22 patients with locally advanced or borderline resectable pancreatic cancer
US FDA approved protocol amendment to launch new cohort evaluating RT-activated NBTXR3 combined with standard-of-care concurrent chemotherapy and recruitment is ongoing
Full data from the completed dose escalation and dose expansion cohorts to be presented at a medical congress in 1H 2025PARIS and CAMBRIDGE, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to expand treatment possibilities...
Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
Written by Customer Service on . Posted in Public Companies.
CHMP opinion now expected in 1Q 2025
No Major Objections outstanding; continue to expect Germany launch in 2Q 2025
PITTSBURGH, Dec. 09, 2024 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) cancelled the Oral Explanation regarding the Company’s Marketing Authorization Application for beremagene geperpavec-svdt (B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB) that was scheduled for December 6, 2024, and asked the Company to submit written responses to the remaining outstanding issues.
There are no Major Objections outstanding from the EMA with respect to the full approval of B-VEC.
“We are confident in our ability to address the remaining...
Tim Keating Joins AMD as Senior Vice President, Government Relations and Regulatory Affairs
Written by Customer Service on . Posted in Public Companies.
SANTA CLARA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) today announced that Tim Keating has joined the company as senior vice president, Government Relations and Regulatory Affairs, effective today.
“Tim is a strong addition to lead our government relations team,” said Ava Hahn, AMD senior vice president, general counsel and corporate secretary. “As high-performance and AI chips play an increasingly larger role in our daily lives over the coming years, Tim’s extensive public policy expertise and deep understanding of regulatory landscapes will play a critical role expanding our engagements with key stakeholders.”
Keating has decades of experience, including more than 14 years at Boeing as executive vice president, Government Relations. Before Boeing, he was the senior vice president of Global Government Operations...
Lee Enterprises and ProRata.ai Announce Groundbreaking Content Partnership to Revolutionize Local News and Advertising
Written by Customer Service on . Posted in Public Companies.
DAVENPORT, Iowa, Dec. 09, 2024 (GLOBE NEWSWIRE) — Lee Enterprises, Inc. (NASDAQ: LEE), a leading provider of trusted local journalism across the United States, today announced a first-of-its-kind content partnership with ProRata.ai, an innovator in artificial intelligence-driven solutions. This partnership marks a pivotal milestone in the evolution of hyper-personalized local content and real-time advertising solutions tailored to the unique needs of local search and AI search engines.
Through this partnership, Lee Enterprises and ProRata.ai will collaborate on groundbreaking technology integration and co-development efforts to bring a cutting-edge attribution platform to local media. The alliance aims to redefine how local news and advertising are delivered, enabling hyper-personalized content experiences and seamless real-time...
Oil-Dri Announces Record Results for the First Quarter of Fiscal Year 2025
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
CHICAGO, Dec. 09, 2024 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its first quarter of fiscal year 2025.
First Quarter(in thousands, except per share amounts)
Ended October 31,
2024
2023
ChangeConsolidated Results
Net Sales
$
127,945
$
111,438
15
%Operating Income (Including Unallocated Corporate Expenses)
$
21,190
$
13,156
61
%Net Income
$
16,376
$
10,742
52
%EBITDA †
$
26,167
$
17,384
51
%Diluted EPS – Common
$
2.25
$
1.50
50
%Business to Business
Net Sales
$
48,415
$
39,161
24
%Segment Operating Income
$
17,110
$
11,123
54
%Retail and Wholesale
Net Sales
$
79,530
$
72,277
10
%Segment Operating Income
$
13,377
$
11,331
18
%† Please refer...
HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Highlights of the third quarter include:Revenue of $300.4 million, an increase of 21% compared to $249.2 million in Q3 FY24.
Net income of $5.7 million, compared to $14.7 million in Q3 FY24, with non-GAAP net income of $69.4 million, an increase of 33% compared to $52.2 million in Q3 FY24.
Net income per diluted share of $0.06, compared to $0.17 in Q3 FY24, with non-GAAP net income per diluted share of $0.78, compared to $0.60 in Q3 FY24.
Adjusted EBITDA of $118.2 million, an increase of 24% compared to $95.6 million in Q3 FY24.
9.5 million HSAs, an increase of 15% compared to Q3 FY24.
Total HSA Assets of $30.0 billion, an increase of 33% compared to Q3 FY24.
16.5 million Total Accounts, including both HSAs and complementary CDBs, an increase of 8% compared to Q3 FY24.
The Company repurchased 0.7 million shares of its common stock for...
Nokia Corporation: Repurchase of own shares on 09.12.2024
Written by Customer Service on . Posted in Public Companies.
Nokia CorporationStock Exchange Release9 December 2024 at 22:30 EET
Nokia Corporation: Repurchase of own shares on 09.12.2024
Espoo, Finland – On 9 December 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code)
Number of shares
Weighted average price / share, EUR*XHEL
872,093
4.18CEUX
–
–BATE
–
–AQEU
–
–TQEX
–
–Total
872,093
4.18* Rounded to two decimals
On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014...